Dosage plasmatique des medicaments antidépresseurs [Recommendations for therapeutic monitoring of antidepressants].


Autoria(s): Baumann P.; Rougemont M.; Corruble E.; Hiemke C.; Groupe AGNP-DPM
Data(s)

2013

Resumo

Therapeutic drug monitoring (TDM), combined in certain situations with pharmacogenetic tests of metabolism, has proven a valuable tool for psychopharmacotherapy. Uncertain drug adherence, suboptimal tolerability, nonresponse at therapeutic doses, or pharmacokinetic drug-drug interactions are typical situations when measurement of medication concentrations is helpful. This article is an adaptation of guidelines recently issued by the AGNP-TDM group (Hiemke et al., www. agnp.de), but its content focuses mainly on the TDM of antidepressants. Finally, the potential benefits of TDM for optimization of pharmacotherapy can only be obtained if the method is adequately integrated into the clinical treatment process.

Identificador

http://serval.unil.ch/?id=serval:BIB_6434029EF865

isbn:1660-9379 (Print)

pmid:23534245

Idioma(s)

fr

Direitos

info:eu-repo/semantics/openAccess

Fonte

Revue Médicale Suisse, vol. 9, no. 377, pp. 577-586

Tipo

info:eu-repo/semantics/review

article